FORTRESS BIOTECH INC

Fortress Biotech CFO Jin David’s 400,000‑unit grant signals strong insider confidence in the company’s long‑term growth prospects.

Fortress Biotech CFO’s insider buy signals confidence amid volatility, with insider activity suggesting alignment with shareholder value and future growth potential.

Fortress Biotech insiders buy 475k shares at no cash cost, signaling confidence amid volatility; investors should watch for upcoming milestones that could lift the price.